Clinical Trial Update: Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC

View source ↗

Summary

This entry reports an ongoing clinical trial evaluating chemoembolization using LifePearl polyethylene glycol drug-eluting microspheres loaded with doxorubicin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• LifePearl Doxorubicin-eluting microspheres (doxorubicin-eluting polyethylene glycol drug-eluting microspheres)

Snippet

Sponsor: International Group of Endovascular Oncology | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN